Clinical Trial Update: Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated whether quercetin can increase claudin-4 and improve esophageal barrier function in Gastroesophageal Reflux Disease; the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Gastroesophageal Reflux Disease, GERD | Phase 1 | Status: COMPLETED